Dacomitinib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11963 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 71 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid arthritis | KG + DL |
| 2 | homozygous familial hypercholesterolemia | KG + DL |
| 3 | brachydactyly-syndactyly syndrome | KG + DL |
| 4 | pulmonary hypertension | KG + DL |
| 5 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 6 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 7 | kyphoscoliotic heart disease | KG + DL |
| 8 | multiple endocrine neoplasia | KG + DL |
| 9 | amyotrophic lateral sclerosis | KG + DL |
| 10 | leprosy | KG + DL |
| 11 | Prinzmetal angina | KG + DL |
| 12 | migraine disorder | KG + DL |
| 13 | hyperthyroidism | KG + DL |
| 14 | female breast carcinoma | KG + DL |
| 15 | Mills syndrome | KG + DL |
| 16 | amyotrophic lateral sclerosis, susceptibility to | KG + DL |
| 17 | amyotrohpic lateral sclerosis type 22 | KG + DL |
| 18 | migraine with brainstem aura | KG + DL |
| 19 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 20 | migraine with or without aura, susceptibility to | KG + DL |
| 21 | axial spondylometaphyseal dysplasia | KG + DL |
| 22 | thrombotic disease | KG + DL |
| 23 | bilateral parasagittal parieto-occipital polymicrogyria | KG + DL |
| 24 | trichomegaly-retina pigmentary degeneration-dwarfism syndrome | KG + DL |
| 25 | lethal arthrogryposis-anterior horn cell disease syndrome | KG + DL |
| 26 | monomelic amyotrophy | KG + DL |
| 27 | coronary artery disease | KG + DL |
| 28 | lower motor neuron syndrome with late-adult onset | KG + DL |
| 29 | hypoalphalipoproteinemia | KG + DL |
| 30 | collagenopathy | KG + DL |
| 31 | vein disease | KG + DL |
| 32 | lymphocytic hypereosinophilic syndrome | KG + DL |
| 33 | Jeune syndrome situs inversus | KG + DL |
| 34 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 35 | Laubry-Pezzi syndrome | KG + DL |
| 36 | heart disease | KG + DL |
| 37 | orofacial clefting syndrome | KG + DL |
| 38 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 39 | angiodysplasia | KG + DL |
| 40 | disorder of fucoglycosan synthesis | KG + DL |
| 41 | non-inflammatory vasculopathy | KG + DL |
| 42 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 43 | interventricular septum aneurysm | KG + DL |
| 44 | autosomal dominant mitochondrial myopathy with exercise intolerance | KG + DL |
| 45 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 46 | pulmonary valve disease | KG + DL |
| 47 | venous thromboembolism | KG + DL |
| 48 | fibrocartilaginous embolism | KG + DL |
| 49 | heart conduction disease | KG + DL |
| 50 | cor pulmonale | KG + DL |
(Showing top 50 of 71 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.